文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

ICU入住时急性肾损伤严重程度与健康结局:基于人群的队列研究

Health outcomes according to severity of acute kidney injury at ICU admission: a population-based cohort study.
PubMed 文献 · Intensive Care Med · 2026-02-05
一句话结论ICU入住时按KDIGO标准判定的AKI严重程度与90天死亡及KRT依赖风险呈分级相关,2期与3期AKI死亡风险相似且均高。

该研究纳入2009-2021年加拿大安大略省484,956例有门诊基线肌酐的成人ICU患者,按KDIGO标准判定入ICU时AKI。AKI发生率为22%(105,671例)。相对无AKI,1期AKI的90天死亡aOR为1.89(95%CI 1.85-1.93),2期aOR 2.64(95%CI 2.54-2.73),3期aOR 2.54(95%CI 2.45-2.63)。90天KRT依赖风险随AKI分期递增:1期aOR 2.05(95%CI 1.79-2.34),2期aOR 4.28(95%CI 3.40-5.40),3期aOR 8.61(95%CI 7.71-9.62)。作者结论认为ICU入住时AKI的存在及严重程度与不良结局强相关,2期和3期AKI预示相似的高死亡风险。

要点

  • ICU入住时AKI发生率为22%(105,671/484,956),按KDIGO标准判定。
  • 相对无AKI,1期AKI的90天死亡aOR 1.89(95%CI 1.85-1.93),2期aOR 2.64(95%CI 2.54-2.73),3期aOR 2.54(95%CI 2.45-2.63)。
  • 2期与3期AKI的90天死亡风险相似且均高(aOR分别为2.64与2.54)。
  • 90天KRT依赖风险随AKI分期递增:1期aOR 2.05(95%CI 1.79-2.34),2期aOR 4.28(95%CI 3.40-5.40),3期aOR 8.61(95%CI 7.71-9.62)。
  • 研究强调需以可靠的基线肾功能评估ICU入住时AKI分期以进行预后分层。

适用人群与场景

  • 加拿大安大略省所有成人(≥18岁)ICU患者,且有可用的门诊基线肌酐测量值,2009-2021年。
  • 队列共484,956例,女性占43%,平均(SD)年龄68(15)岁,平均(SD)基线eGFR 77(25)mL/min/1.73 m2。

诊断标准与关键阈值

  • AKI按肾脏病改善全球预后(KDIGO)标准判定,于ICU入住时评估。
  • AKI分期为1期、2期、3期;无AKI为参照。

研究设计与关键结果

  • 研究类型:基于人群的队列研究;样本量484,956例成人ICU患者;人群为加拿大安大略省居民,2009-2021年入住ICU且有门诊基线肌酐。
  • AKI发生率为22%(105,671例)。
  • 主要终点90天死亡:相对无AKI,1期AKI aOR 1.89(95%CI 1.85-1.93),2期aOR 2.64(95%CI 2.54-2.73),3期aOR 2.54(95%CI 2.45-2.63)。
  • 关键次要终点90天KRT依赖:相对无AKI,1期aOR 2.05(95%CI 1.79-2.34),2期aOR 4.28(95%CI 3.40-5.40),3期aOR 8.61(95%CI 7.71-9.62)。
  • 结论:ICU入住时AKI的存在及严重程度与不良健康结局强相关;2期和3期AKI预示相似的高死亡风险。

证据类型、等级与局限

  • 证据类型:基于人群的队列研究(population-based cohort study)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对ICU入住患者应依据KDIGO标准评估AKI分期,并尽量获取门诊基线肌酐以可靠判定基线肾功能。
  • 入住时AKI分期可用于预后分层:1期、2期、3期AKI的90天死亡和KRT依赖风险均高于无AKI,且KRT依赖风险随分期递增。
  • 作者认为ICU入住时AKI的存在及严重程度与不良结局强相关,2期和3期AKI预示相似的高死亡风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: The presence and severity of acute kidney injury (AKI) upon ICU admission provides important short- and long-term prognostic information. Existing reports have been limited by inadequate baseline kidney function assessment, incomplete outcome capture, limited adjustment for illness severity, and small sample sizes.

METHODS: We conducted a population-level study of all adult (≥ 18 years) Ontario, Canada residents with available outpatient baseline creatinine measurements admitted to the ICU from 2009-2021. AKI at the time of ICU admission was determined according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria. Outcomes included death and kidney replacement therapy (KRT). Multivariable logistic regression modeling was used to estimate adjusted odds ratios (aOR).

RESULTS: The study cohort included 484,956 adults (43% female) admitted to the ICU. Mean (SD) age and baseline eGFR were 68 (15) years and 77 (25) mL/min/1.73 m2, respectively. AKI was present in 105,671 (22%). Relative to no AKI, stage 1 AKI was associated with approximately twofold higher odds for 90-day mortality (aOR 1.89 [95% CI 1.85-1.93]) while stages 2 and 3 AKI were associated with approximately 2.5-fold higher odds (stage 2 aOR 2.64 [95% CI 2.54-2.73], stage 3 aOR 2.54 [95% CI 2.45-2.63]). Relative to no AKI, there was a progressively increased risk for KRT dependence at 90 days: stage 1 (aOR 2.05 [95% CI 1.79-2.34]), stage 2 (aOR 4.28 [95% CI 3.40-5.40]), and stage 3 (aOR 8.61 [95% CI 7.71-9.62]).

CONCLUSION: The presence and severity of AKI at the time of ICU admission are strongly associated with adverse health outcomes. Stage 2 and 3 AKI portend a similarly high risk of mortality.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hundemer GL, Dumicho AY, Knoll GA, et al. Health outcomes according to severity of acute kidney injury at ICU admission: a population-based cohort study. Intensive Care Med. 2026. PMID: 41642328. doi:10.1007/s00134-026-08317-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。